Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 9-18

  Sachdeva, Vishal ^a   Bai, Yun ^a   Kydonieus, Agis ^b   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

^b Agile Therapeutics   (United States)

Author keywords

Acrylate adhesive; Contraceptive; Crystallization; Desogestrel; Polyisobutylene adhesive; Transdermal patch

Indexed keywords

ACRYLIC ACID; COPOVIDONE; DESOGESTREL; EXCIPIENT; ISOBUTYLENE; LEVONORGESTREL; MINERAL OIL; UNCLASSIFIED DRUG;

ARTICLE; CONTRACEPTION; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; FEMALE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY;

ADHESIVES; ANIMALS; CONTRACEPTIVES, ORAL, SYNTHETIC; CRYSTALLIZATION; DESOGESTREL; EXCIPIENTS; LEVONORGESTREL; MALE; MINERAL OIL; PYRROLIDINES; RATS; RATS, HAIRLESS; REPRODUCIBILITY OF RESULTS; SKIN ABSORPTION; SOLUBILITY; TRANSDERMAL PATCH; VINYL COMPOUNDS;

EID: 84871876411     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.12.014     Document Type: Article

References (33)

1. A.K. Banga Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies 2011 Taylor and Francis London
2. M.D. Barratt Quantitative structure-activity relationships for skin permeability Toxicol. In Vitro 9 1995 27 37
3. K.R. Chaudhuri Crystallisation within transdermal rotigotine patch: is there cause for concern? Expert Opin. Drug Deliv. 5 2008 1169 1171
4. M.N. Chisty, R.A. Bellantone, D.R. Taft, and F.M. Plakogiannis In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes Drug Dev. Ind. Pharm. 28 2002 1221 1229
5. F. Cilurzo, P. Minghetti, A. Casiraghi, L. Tosi, S. Pagani, and L. Montanari Poly-methacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen Eur. J. Pharm. Biopharm. 60 2005 61 66
6. Drug Bank and Database 2012. http://www.drugbank.ca/drugs/DB00304 (accessed 07.11.12).
7. FDA Guidance for Industry Residual Drug in Transdermal and Related Drug Delivery Systems 2010 Food and Drug Administration pp. 1-3
8. P. Foreman, A. Hansen, E. Silverberg, T. Manegold, H. Yang, J. Li, and S. Jacobson Predicting Drug Solubility in Transdermal Adhesives 2002 American Association of Pharmaceutical Scientists (AAPS), National Starch and Chemical Company
9. T.K. Ghosh, W.R. Pfister, and S.I. Yum Transdermal and Topical Drug Delivery Systems 1997 Interpharm Press Inc. Buffalo Groove, IL
10. J. Hadgraft Passive enhancement strategies in topical and transdermal drug delivery Int. J. Pharm. 184 1999 1 6
11. P. Jain, and A.K. Banga Inhibition of crystallization in drug-in-adhesive-type transdermal patches Int. J. Pharm. 394 2010 68 74
12. S.K. Jain, M.K. Chourasia, M. Sabitha, R. Jain, A.K. Jain, M. Ashawat, and A.K. Jha Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride Drug Deliv. 10 2003 169 177
13. J.H. Kim, and H.K. Choi Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix Int. J. Pharm. 236 2002 81 85
14. P.N. Kotiyan, and P.R. Vavia Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol Eur. J. Pharm. Biopharm. 52 2001 173 180
15. P. Lammers, P.D. Blumenthal, and G.R. Huggins Developments in contraception: a comprehensive review of desogen (desogestrel and ethinyl estradiol) Contraception 57 1998 1S 27S
16. S. Latsch, T. Selzer, L. Fink, and J. Kreuter Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry X-ray diffraction, and optical microscopy Eur. J. Pharm. Biopharm. 57 2004 383 395
17. Lexi-Drugs Online 2012. http://online.lexi.com.proxy.mercer.edu/lco/ action/doc/retrieve/docid/patch-f/6867. Lexi-drugs online (accessed 07.11.12).
18. Lipp, R., Gunther, C., Riedl, J., Tauber, U., 1995. Desogestrel containing transdermal application agent. Canadian patent document no. CA 2183544, Canadian Intellectual Property Office. http://brevets-patents.ic.gc.ca/ opic-cipo/cpd/eng/patent/2183544/summary.html (accessed 07.11.12).
19. R. Lipp Selection and use of crystallization inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids J. Pharm. Pharmacol. 50 1998 1343 1349
20. R. Lipp, and A. Muller-Fahrnow Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems Eur. J. Pharm. Biopharm. 47 1999 133 138
21. X. Ma, J. Taw, and C.M. Chiang Control of drug crystallization in transdermal matrix system Int. J. Pharm. 142 1996 115 119
22. D. Matejicek, and V. Kuban High performance liquid chromatography/ion- trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel Anal. Chim. Acta 588 2007 304 315
23. P. Minghetti, F. Cilurzo, and L. Montanari Evaluation of adhesive properties of patches based on acrylic matrices Drug Dev. Ind. Pharm. 25 1999 1 6
24. P. Minghetti, F. Cilurzo, S. Pagani, A. Casiraghi, R. Assandri, and L. Montanari Formulation study of oxybutynin patches Pharm. Dev. Technol. 12 2007 239 246
25. R.O. Potts, and R.H. Guy Predicting skin permeability Pharm. Res. 9 1992 663 669
26. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
27. M. Schulz, B. Fussnegger, and R. Bodmeier Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel Eur. J. Pharm. Biopharm. 77 2011 240 248
28. R. Sitruk-Ware Transdermal application of steroid hormones for contraception J. Steroid Biochem. Mol. Biol. 53 1995 247 251
29. R.K. Subedi, S.Y. Oh, M.K. Chun, and H.K. Choi Recent advances in transdermal drug delivery Arch. Pharm. Res. 33 2010 339 351
30. H.S. Tan, and W.R. Pfister Pressure-sensitive adhesives for transdermal drug delivery systems Pharm. Sci. Technolo. Today 2 1999 60 69
31. S. Valiveti, P.K. Kiptoo, D.C. Hammell, and A.L. Stinchcomb Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro Int. J. Pharm. 278 2004 173 180
32. N.E. Variankaval, K.I. Jacob, and S.M. Dinh Crystallization of beta-estradiol in an acrylic transdermal drug delivery system J. Biomed. Mater. Res. 44 1999 397 406
33. J. Yu, T. Chien, and Y.W. Chien Transdermal dual-controlled delivery of testosterone and estradiol: (I) impact of system design Drug Dev. Ind. Pharm. 17 1991 1883 1904